Vivodyne

Human data before the clinic

San Francisco Bay Area, United States · Founded 2022 · $78.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$78.0M
Last Round
$40.0M Series AMay 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Vivodyne is a biotechnology company that accelerates drug discovery by testing therapeutics on thousands of lab-grown human organ models using robotic automation and AI. Their proprietary Data Engine platform runs massive parallel studies on over 10,000 independent human tissues at a time, generating clinically predictive preclinical data without relying on animal testing. Vivodyne's multimodal AI integrates 3D phenomics, single-cell transcriptomics, and proteomics to identify new drug targets and optimize candidates before clinical trials.

Summary

Vivodyne is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2022. It has raised $78.0M in total across 2 rounds, most recently a $40.0M Series A round in May 2025. Investors include Khosla Ventures, Kairos Ventures and CS Ventures.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2025
$40.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vivodyne on Indexed.vc
<a href="https://indexed.vc/companies/vivodyne"><img src="https://indexed.vc/api/badge/company/vivodyne" alt="Vivodyne on Indexed.vc" width="260" height="76" /></a>